Nakashima K, Schenkein H A, Califano J V, Tew J G
Clinical Research Center for Periodontal Diseases, School of Dentistry, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
Infect Immun. 1997 Sep;65(9):3794-8. doi: 10.1128/iai.65.9.3794-3798.1997.
The serotype b-specific carbohydrate antigen (SbAg) of Actinobacillus actinomycetemcomitans Y4 is reported to be the O antigen of lipopolysaccharide, and the highest titers of serum antibody reactive with A. actinomycetemcomitans in early-onset periodontitis (EOP) patients bind SbAg. These high titers of serum antibody reactive with SbAg are associated with a lesser extent and severity of periodontal disease. The aim of this study was to determine if a limited number of genes code for anti-SbAg antibodies as has been shown for immunoglobulin G (IgG) reactive with the type b polysaccharide from Haemophilus influenzae. Serum IgG reactive with the SbAg was prepared from 20 high-titer EOP patients by affinity chromatography. The IgG subclass concentrations were determined, and heterogeneity was analyzed by isoelectric focusing (IEF). IgG2 was the dominant subclass (83% of total IgG) in the anti-SbAg IgG fraction and represented an average of 1.33% of total serum IgG2. The IgG2 reactive with SbAg was isolated from the affinity-purified IgG fraction by affinity chromatography with protein A and subclass-specific monoclonal antibodies. On IEF gels, only 4 to 20 bands were observed in the anti-SbAg IgG fractions, indicating limited heterogeneity. N-terminal amino acid sequence analysis of eight representative anti-SbAg IgG2 preparations indicated that variable heavy and light chains consisted largely of V(H)III and V(kappa)II, respectively. However, a significant fraction of anti-SbAg may use V(H) and V(lambda) genes with blocked N termini. In short, these findings indicate that IgG reactive with SbAg is very much like the antibody reactive with H. influenzae type b polysaccharide. Similarities include IgG2 dominance, limited bands on IEF gels, supporting an oligoclonal response, and use of genes from V(H)III and V(kappa)II regions.
据报道,伴放线放线杆菌Y4的b型特异性碳水化合物抗原(SbAg)是脂多糖的O抗原,早期牙周炎(EOP)患者中与伴放线放线杆菌反应的血清抗体最高滴度与SbAg结合。这些与SbAg反应的高滴度血清抗体与牙周疾病的程度和严重程度较低有关。本研究的目的是确定是否像与流感嗜血杆菌b型多糖反应的免疫球蛋白G(IgG)那样,有限数量的基因编码抗SbAg抗体。通过亲和层析从20例高滴度EOP患者中制备与SbAg反应的血清IgG。测定IgG亚类浓度,并通过等电聚焦(IEF)分析其异质性。IgG2是抗SbAg IgG组分中的主要亚类(占总IgG的83%),平均占总血清IgG2的1.33%。通过用蛋白A和亚类特异性单克隆抗体进行亲和层析,从亲和纯化的IgG组分中分离出与SbAg反应的IgG2。在IEF凝胶上,抗SbAg IgG组分中仅观察到4至20条带,表明异质性有限。对8种代表性抗SbAg IgG2制剂进行N端氨基酸序列分析表明,可变重链和轻链在很大程度上分别由V(H)III和V(kappa)II组成。然而,相当一部分抗SbAg可能使用N端封闭的V(H)和V(lambda)基因。简而言之,这些发现表明与SbAg反应的IgG与与流感嗜血杆菌b型多糖反应的抗体非常相似。相似之处包括IgG2占主导地位、IEF凝胶上条带有限,支持寡克隆反应,以及使用来自V(H)III和V(kappa)II区域的基因。